Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptid
Kurzübersicht für Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptid (ABIN940092)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KVHLEGFNDE DVISRQDHEQ ETEKLELEIQ QCKEMIKTQQ QLLQQQLATA
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 IP antibody,
Alternative Names: SSX2IP control peptide, SSX2IP antibody Blocking Peptide, Anti-SSX2IP Blocking Peptide, Synovial Sarcoma X Breakpoint 2 Interacting Protein Blocking Peptide, ADIP Blocking Peptide, FLJ10848 Blocking Peptide, KIAA0923 Blocking Peptide, MGC75026 Blocking Peptide, SSX2IP, SSXIP-2, SSXIP 2, SSXIP-2 Blocking Peptide, SSXIP 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
-
Hintergrund
- SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
-
Molekulargewicht
- 68 kDa
Target
-